A decreasing trend was observed; however, a one-sample t test showed no significant difference with treatment [ Figure 4A ; t (16) = 0.28, p = 0.79].
← all excerpts
Evaluation of the safety and potential lipid-lowering effects of oral hydrogen-rich coral calcium (HRCC) capsules in patients with metabolic syndrome: a prospective case series study.
1
—
—